Total Funding
82
72
Total FundingSeries B raised
Growth Score 82 in past quarter
-4 pts
Heat Score 72 in past quarter
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
755594
AviGenics is a biotechnology company
About the Company
AviGenics is a biotechnology company developing therapeutic proteins for oncology, infectious diseases and autoimmune diseases. AviGenics’ proprietary technology produces therapeutic proteins with human-like glycosylation, leading to well tolerated products with increased half-life and enhanced clinical efficacy. Using this technology, the Company
has demonstrated that it can achieve commercially feasible levels of production and purification for therapeutic proteins.
